论文信息 - SAFETY, PHARMACOKINETICS (PK), AND FLORBETAPIR F-18 POSITRON EMISSION TOMOGRAPHY (PET) AFTER MULTIPLE DOSE ADMINISTRATION OF LY3002813, A β-AMYLOID PLAQUE-SPECIFIC ANTIBODY, IN ALZHEIMER’S DISEASE (AD) - 字舞流文

SAFETY, PHARMACOKINETICS (PK), AND FLORBETAPIR F-18 POSITRON EMISSION TOMOGRAPHY (PET) AFTER MULTIPLE DOSE ADMINISTRATION OF LY3002813, A β-AMYLOID PLAQUE-SPECIFIC ANTIBODY, IN ALZHEIMER’S DISEASE (AD)

M. Mintun | R. Dean | Peng Liu | A. Schwarz | M. Irizarry | M. Devous | S. Shcherbinin | B. Willis | R. Konrad | S. Lowe | A. Hawdon | M. Nakano | C. Gonzales | J. Sims | Shino Fujimoto | R. DeMattos